Small-cell lung cancer with voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis: A case report

被引：13

作者：

Kaira K. ^{[1
]}

Okamura T. ^{[1
]}

Takahashi H. ^{[1
]}

Horiguchi N. ^{[1
]}

Sunaga N. ^{[1
]}

Hisada T. ^{[1
]}

Yamada M. ^{[1
]}

机构：

[1] Department of Medicine and Molecular Science, Graduate School of Medicine, Gunma University, Showa-machi, Maebashi

来源：

Journal of Medical Case Reports | / 8卷 / 1期

关键词：

Paraneoplastic limbic encephalitis; Small-cell lung cancer; VGCC;

D O I：

10.1186/1752-1947-8-119

中图分类号：

学科分类号：

摘要：

Introduction. Paraneoplastic limbic encephalitis is a rare neurological syndrome and clinically characterized by cognitive dysfunction, memory impairment, seizures and psychiatric symptoms. Paraneoplastic limbic encephalitis is most frequently found in small-cell lung cancer, among various malignancies, and antineuronal antibodies are related to the autoimmune mechanism. We experienced a rare case of a patient with small-cell lung cancer with anti-voltage-gated calcium channel antibody-positive paraneoplastic limbic encephalitis. Case presentation. A 61-year-old Japanese man with a history of smoking cigarettes presented with seizure, confusion and personality change in acute onset. Brain magnetic resonance imaging showed high signal intensity on T2-weighted image in his right temporal lobe, suggestive of limbic encephalitis. A mediastinoscopy of the lymph node revealed small-cell lung carcinoma, and he was staged as having limited stage disease. Antibodies against P/Q-type and N-type voltage-gated calcium channel were positive and Hu antibody was negative. He was started on chemotherapy of carboplatin plus etoposide with concurrent thoracic radiotherapy. Neurological symptoms were gradually improved after systemic chemotherapy. Conclusions: We should be alert to the potential of malignant neoplasms associated with paraneoplastic limbic encephalitis when we examine a patient with cancer with neurological disorders such as personality change, disorientation, unconsciousness and memory loss. A clinical marker such as voltage-gated calcium channel antibody may help our diagnosis in clinical practice. © 2014 Kaira et al.; licensee BioMed Central Ltd.

引用

共 10 条

[1] Gultekin S.H., Rosenfeld M.R., Voltz R., Eichen J., Posner J.B., Dalmau J., Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients, Brain, 123, 7, pp. 1481-1494, (2000)
[2] Alamowitch S., Graus F., Uchuya M., Rene R., Bescansa E., Delattre J.Y., Limbic encephalitis and small cell lung cancer. Clinical and immunological features, Brain, 120, 6, pp. 923-928, (1997)
[3] Payne M., Bradbury P., Lang B., Vincent A., Han C., Newsom-Davis J., Talbot D., Prospective study into the incidence of Lambert Eaton Myasthenic Syndrome in small cell lung cancer, J Thorac Oncol, 5, pp. 34-38, (2010)
[4] Monstad S.E., Drivsholm L., Storstein A., Aarseth J.H., Haugen M., Lang D., Vincent A., Vedeler C.A., Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer, Journal of Clinical Oncology, 22, 5, pp. 795-800, (2004)
[5] Graus F., Lang B., Pozo-Rosich P., Saiz A., Casamitjana R., Vincent A., P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer, Neurology, 59, pp. 764-766, (2002)
[6] Kleopa K.A., Teener J.W., Scherer S.S., Galetta S.L., Bird S.J., Chronic multiple paraneoplastic syndromes, Muscle Nerve, 23, pp. 1767-1772, (2000)
[7] Weimer T., Boling W., Pryputniewicz D., Palade A., Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis, J Neurosurg, 109, pp. 742-745, (2008)
[8] Xia Z., Mehta B.P., Ropper A.H., Kesari S., Paraneoplastic limbic encephalitis presenting as a neurological emergency: A case report, J Med Case Reports, 4, (2010)
[9] Cakrer S., Paraneoplastic limbic encephalitis: Case report, Computerized Medical Imaging and Graphics, 26, 1, pp. 55-58, (2002)
[10] Schaller B.J., Modo M., Buchfelder M., Molecular imaging of brain tumors: A bridge between clinical and molecular medicine?, Molecular Imaging and Biology, 9, 2, pp. 60-71, (2007)

← 1 →